Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-PD1-activated TILs and chemotherapy in stage II-IIIA NSCLC
NCT03903887Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Feb 2019
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Phase 2, open-label trial in non-small cell lung cancer (NSCLC), sponsored by Sun Yat-sen University. Status: unknown.
02
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03903887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03903887.